TABLE 3.
CIRCULATING BIOMARKERS AT BASELINE AND END OF INTERVENTION (EOI)
| Measure | Baseline Mean (s.d.) | EOI Mean (s.d.) | p-value |
|---|---|---|---|
| Adipokines and Cytokines | |||
| Adiponectin (μg/mL)1 | 9.42 (0.88) | 9.37 (0.99) | 0.60 |
| Leptin (ng/mL) | 30.69 (14.83) | 31.65 (18.66) | 0.66 |
| IL-6 (pg/mL) | 2.88 (1.26) | 2.94 (1.17) | 0.33 |
| TNF-α (pg/mL) | 2.41 (1.13) | 2.20 (1.19) | 0.24 |
| Hormones | |||
| Insulin (μIU/mL)1 | 2.53 (0.48) | 2.35 (0.58) | 0.15 |
| C-peptide (pg/mL) | 893.88 (399.11) | 723.86 (318.98) | 0.01 |
| PP (pg/mL) | 38.32 (22.12) | 27.30 (29.01) | 0.15 |
| PYY (pg/mL) | 46.07 (17.05) | 47.28 (17.56) | 0.34 |
| Growth Factors | |||
| IGF-1 (ng/mL) | 72.63 (28.03) | 73.19 (26.58) | 0.90 |
| IGFBP-3 (ng/mL)1 | 7.64 (0.20) | 7.64 (0.17) | 0.98 |
1
geometric mean